Lactate, histone lactylation and cancer hallmarks
2023 · Expert Reviews in Molecular Medicine · 189 citations
https://doi.org/10.1017/erm.2022.42
X
Xiaofeng Dai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
212
Papers
7.0K
Citations
36
h-index
102
i10-index
Xiaofeng Dai is an academic researcher from Nanchang University. The author has contributed to research in topics: Plasma Applications and Diagnostics & RNA modifications and cancer & Epigenetics and DNA Methylation. The author has an h-index of 36, co-authored 181 publications.
ORCID: 0000-0002-0006-4042Papers by this author
worksSystemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
2025 · Signal Transduction and Targeted Therapy · 106 citations
https://doi.org/10.1038/s41392-025-02168-0
Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling
2014 · Scientific Reports · 71 citations
https://doi.org/10.1038/srep06566
Future antiviral polymers by plasma processing
2021 · Progress in Polymer Science · 48 citations
https://doi.org/10.1016/j.progpolymsci.2021.101410
Integrated diagnostic network construction reveals a 4-gene panel and 5 cancer hallmarks driving breast cancer heterogeneity
2017 · Scientific Reports · 37 citations
https://doi.org/10.1038/s41598-017-07189-6
Epidermal growth factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium
2023 · Redox Biology · 26 citations
https://doi.org/10.1016/j.redox.2023.102976
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat